Investors

OvaScience is a global fertility company dedicated to improving treatment options for women around the world.

OVAS (Common Stock)
Price & Exchange
$1.29
NASDAQ
Change (%)
 Stock is Down 0.02 (1.53%)
Volume
190,979
05/26/17      4:00 p.m. ET

Minimum 20 minute delay
Refresh quote

2017 News Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
05/09/17OvaScience Reports First Quarter 2017 Financial Results
–Fertilization of Bovine EggPC Cell-Derived Egg in OvaTure Program on Track for Year-End– –OvaPrime Clinical Trial Progressing Toward Year-End Initial Readout– –Robust Financial Position Supports Corporate Strategy into 1Q19– –Conference Call Today at 4:30 p.m. ET– WALTHAM, Mass.--(BUSINESS WIRE)--May 9, 2017-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercializ... 
Printer Friendly Version
05/02/17OvaScience to Host First Quarter 2017 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--May 2, 2017-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it will host a conference call at 4:30 p.m. ET on Tuesday, May 9, 2017 to discuss first quarter 2017 financial results and provide a general corporate update. The live call can be accessed by dialing + 1-888-424-8151 for U.S. callers... 
Printer Friendly Version
03/02/17OvaScience Reports Fourth Quarter and Year-End 2016 Financial Results
OvaTure Program On Track to Successfully Fertilize a Bovine EggPC Cell-Derived Egg 50 Patients Enrolled in OvaPrime Clinical Trial Cash Position Expected to Support Operations into Q12019 Conference Call Today at 4:30 p.m. ET WALTHAM, Mass.--(BUSINESS WIRE)--Mar. 2, 2017-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, ... 
Printer Friendly Version
02/27/17OvaScience to Present at Upcoming Investor Conferences in March
WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 27, 2017-- OvaScience℠ (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that Christophe Couturier, Chief Financial Officer of OvaScience, will present a corporate overview at two upcoming conferences: Cowen and Company 37th Annual Health Care Conference Date: Monday, March 6, 2017 Time: 2:00 p.m. ET Location: Boston, MA ... 
Printer Friendly Version
02/23/17OvaScience to Host Fourth Quarter and Fiscal Year 2016 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 23, 2017-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it will host a conference call at 4:30 p.m. ET on Thursday, March 2, 2017 to discuss fourth quarter and fiscal year 2016 financial results and provide a general corporate update. The live call can be accessed by dialing +1-888-424-... 
Printer Friendly Version
01/05/17OvaScience to Present at the 35th Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Jan. 5, 2017-- OvaScience℠ (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that Michelle Dipp, M.D., Ph.D., Executive Chair and Co-founder of OvaScience, will present a corporate overview at the 35th Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2017 at 8:30 a.m. PT (11:30 a.m. ET) at the Westin St. ... 
Printer Friendly Version